Evidence map›Paper›PMID 28812277›Full record

ArticleInflammation2017

Milonine, an Alkaloid of Cissampelos sympodialis Eichl. (Menispermaceae) Inhibits Histamine Release of Activated Mast Cells.

Adriano Francisco Alves, Giciane Carvalho Vieira, Francisco Allysson A F Gadelha, Luiz Henrique Agra Cavalcante-Silva, Marco Aurélio Martins, José Maria Barbosa-Filho, Marcia Regina Piuvezam

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Adriano Francisco AlvesLaboratory of Immunopharmacology, Health Sciences Centre, Federal University of Paraíba, João Pessoa, PB, Brazil.
Giciane Carvalho VieiraLaboratory of Immunopharmacology, Health Sciences Centre, Federal University of Paraíba, João Pessoa, PB, Brazil.
Francisco Allysson A F GadelhaLaboratory of Immunopharmacology, Health Sciences Centre, Federal University of Paraíba, João Pessoa, PB, Brazil.
Luiz Henrique Agra Cavalcante-SilvaLaboratory of Immunopharmacology, Health Sciences Centre, Federal University of Paraíba, João Pessoa, PB, Brazil.
Marco Aurélio MartinsLaboratory of Inflammation, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
José Maria Barbosa-FilhoPostgraduate Program in Natural Products and Bioactive Synthetics (PgPNSB), Health Sciences Centre, Federal University of Paraíba, João Pessoa, PB, Brazil.
Marcia Regina PiuvezamLaboratory of Immunopharmacology, Health Sciences Centre, Federal University of Paraíba, João Pessoa, PB, Brazil. mrpiuvezam@ltf.ufpb.br.
Universidade Federal da Paraíba · BRFundação Oswaldo Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Milonine is an alkaloid of Cissampelos sympodialis Eichl. (Menispermaceae), a plant used in the northeast of Brazil to treat allergies such as asthma, rhinitis, and other conditions. Previously, several alkaloids were isolated from its roots and leaves with pharmacological properties in asthma and acute inflammation models. Therefore, the aim of this study was to evaluate the milonine effect on mast cells degranulation in vivo and in vitro. Swiss mice (n = 8) were used in models of paw edema induced by carrageenan, compound 48/80, or histamine. One hour before challenge, the animals were treated with milonine (at different doses) or standard drugs and, at different time points, the edema formation was measured. In addition, other different methods, such as anaphylactic shock reaction and scratching behavior models both induced by compound 48/80, a mast cell degranulator, were used to assess milonine effect histamine release in vivo. Moreover, milonine effect on mast cell degranulation in vitro was also carried out. Firstly, it was observed that milonine significantly decreased the carrageenan edema formation only at the beginning of the reaction (i.e., up to 2 h after challenge). Furthermore, this alkaloid decreased the edema induced by compound 48/80, maintained the paw tissue integrity, without modulating histamine-induced paw edema. In anaphylactic shock reaction, milonine increased the time of animal survival when compared with compound 48/80 group. Milonine also significantly decreased the scratching behavior induced by compound 48/80 with decreasing of mast cell degranulation in vitro. Therefore, these data indicated that milonine presents anti-allergic properties by decreasing mast cell degranulation rather than acting on histamine effect.

Indexed as

AlkaloidsAnaphylaxisAnimalsAnti-Allergic AgentsCissampelosEdemaHistamine ReleaseMast CellsMiceMorphinansPruritusAlkaloidsAnti-Allergic AgentsmilonineMorphinansalkaloidCissampelos sympodialis Eichl. (Menispermaceae)degranulationhistaminemast cellmilonine

Identifiers

PMID28812277
OpenAlexW2750526980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.